Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells.
In embryogenesis, coronary blood vessels are formed by vasculogenesis from epicardium-derived progenitors. Subsequently, growing or regenerating myocardium increases its vasculature by angiogenesis, forming new vessels from the pre-existing ones. Recently, cell therapies for myocardium ischemia that used different protocols have given promising results, using either extra-cardiac blood vessel cell progenitors or stimulating the cardiac angiogenesis. We have questioned whether cardiomyocytes could sustain both vasculogenesis and angiogenesis. We used a 3D culture model of tissue-like spheroids in co-cultures of cardiomyocytes supplemented either with endothelial cells or with bone marrow-derived mesenchymal stroma cells. Murine foetal cardiomyocytes introduced into non-adherent U-wells formed 3D contractile structures. They were coupled by gap junctions. Cardiomyocytes segregated inside the 3D structure into clumps separated by connective tissue septa, rich in fibronectin. Three vascular endothelial growth factor isoforms were produced (VEGF 120, 164 and 188). When co-cultured with human umbilical cord endothelial cells, vascular structures were produced in fibronectin-rich external layer and in radial septa, followed by angiogenic sprouting into the cardiomyocyte microtissue. Presence of vascular structures led to the maintenance of long-term survival and contractile capacity of cardiac microtissues. Conversely, bone marrow mesenchymal cells formed isolated cell aggregates, which progressively expressed the endothelial markers von Willebrand's antigen and CD31. They proceeded to typical vasculogenesis forming new blood vessels organised in radial pattern. Our results indicate that the in vitro 3D model of cardiomyocyte spheroids provides the two basic elements for formation of new blood vessels: fibronectin and VEGF. Within the myocardial environment, endothelial and mesenchymal cells can proceed to formation of new blood vessels either through angiogenesis or vasculogenesis, respectively.
Garzoni
Luciana R
LR
Laboratório de Ultra-Estrutura Celular, Rio de Janeiro, Brazil. largarz@ioc.fiocruz.br
Rossi
Maria Isabel D
MI
de Barros
Ana P D N
AP
Guarani
Virgínia
V
Keramidas
Michelle
M
Balottin
Luciene B L
LB
Adesse
Daniel
D
Takiya
Christina M
CM
Manso
Pedro Paulo
PP
Otazú
Ivone B
IB
Meirelles
Maria de Nazareth
Mde N
Borojevic
Radovan
R
D000818:Animals; D001808:Blood Vessels / Q000254:growth & development; D018920:Coculture Techniques; D003331:Coronary Vessels / Q000502:physiology*; D042783:Endothelial Cells / Q000166:cytology*; D005353:Fibronectins / Q000096:biosynthesis; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D051379:Mice; D032383:Myocytes, Cardiac / Q000166:cytology*; D018919:Neovascularization, Physiologic; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis
D005353:Fibronectins; D042461:Vascular Endothelial Growth Factor A